Found: 187
Select item for more details and to access through your institution.
Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere.
- Published in:
- CardioVascular & Interventional Radiology, 2024, v. 47, n. 9, p. 1210, doi. 10.1007/s00270-024-03726-9
- By:
- Publication type:
- Article
Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack.
- Published in:
- Cerebrovascular Diseases, 2020, v. 49, n. 5, p. 474, doi. 10.1159/000510436
- By:
- Publication type:
- Article
Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients.
- Published in:
- Cerebrovascular Diseases, 2019, v. 47, n. 1/2, p. 32, doi. 10.1159/000497069
- By:
- Publication type:
- Article
Effect of metabolic dysfunction‐associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 975, doi. 10.1111/hepr.13830
- By:
- Publication type:
- Article
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 406, doi. 10.1111/hepr.13600
- By:
- Publication type:
- Article
Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 445, doi. 10.1159/000529824
- By:
- Publication type:
- Article
Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study.
- Published in:
- Modern Rheumatology, 2020, v. 30, n. 1, p. 70, doi. 10.1080/14397595.2018.1558760
- By:
- Publication type:
- Article
Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 4, p. 576, doi. 10.3109/14397595.2015.1113629
- By:
- Publication type:
- Article
Hepatitis B Reactivation and Vaccination Effectiveness after Solid Organ Transplantation: A Matched Case-Control Study.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 804, doi. 10.3390/vaccines12070804
- By:
- Publication type:
- Article
Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model.
- Published in:
- Gastroenterology Report, 2022, v. 10, p. 1, doi. 10.1093/gastro/goac037
- By:
- Publication type:
- Article
Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39043-2
- By:
- Publication type:
- Article
Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 24, p. 13214, doi. 10.3390/ijms222413214
- By:
- Publication type:
- Article
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B.
- Published in:
- Liver International, 2023, v. 43, n. 8, p. 1813, doi. 10.1111/liv.15597
- By:
- Publication type:
- Article
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2023, v. 43, n. 3, p. 608, doi. 10.1111/liv.15508
- By:
- Publication type:
- Article
Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk.
- Published in:
- Liver International, 2022, v. 42, n. 8, p. 1902, doi. 10.1111/liv.15282
- By:
- Publication type:
- Article
External validation of the modified PAGE‐B score in Asian chronic hepatitis B patients receiving antiviral therapy.
- Published in:
- Liver International, 2019, v. 39, n. 9, p. 1624, doi. 10.1111/liv.14129
- By:
- Publication type:
- Article
Fibrosis‐matched outcomes between chronic hepatitis B patients with drug‐induced virological response and inactive carriers.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 81, doi. 10.1111/liv.13948
- By:
- Publication type:
- Article
Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib.
- Published in:
- Liver International, 2018, v. 38, n. 9, p. 1655, doi. 10.1111/liv.13731
- By:
- Publication type:
- Article
Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B.
- Published in:
- Liver International, 2018, v. 38, n. 4, p. 676, doi. 10.1111/liv.13583
- By:
- Publication type:
- Article
Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir.
- Published in:
- Liver International, 2017, v. 37, n. 12, p. 1788, doi. 10.1111/liv.13450
- By:
- Publication type:
- Article
Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.
- Published in:
- Liver International, 2017, v. 37, n. 6, p. 879, doi. 10.1111/liv.13341
- By:
- Publication type:
- Article
Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.
- Published in:
- Journal of Surgical Oncology, 2008, v. 97, n. 3, p. 246, doi. 10.1002/jso.20953
- By:
- Publication type:
- Article
Selective tuning of activity in a multifunctional enzyme as revealed in the F21W mutant of dehaloperoxidase B from <italic>Amphitrite ornata</italic>.
- Published in:
- Journal of Biological Inorganic Chemistry (JBIC), 2018, v. 23, n. 2, p. 209, doi. 10.1007/s00775-017-1520-x
- By:
- Publication type:
- Article
Clinical Application of Liver Stiffness Measurement Using Transient Elastography: A Surgical Perspective.
- Published in:
- Digestion, 2013, v. 88, n. 4, p. 258, doi. 10.1159/000355948
- By:
- Publication type:
- Article
Prediction of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis Using the P2/MS Noninvasive Index Based on Complete Blood Counts.
- Published in:
- Digestion, 2012, v. 86, n. 3, p. 264, doi. 10.1159/000341507
- By:
- Publication type:
- Article
Risk Assessment of Development of Hepatic Decompensation in Histologically Proven Hepatitis B Viral Cirrhosis Using Liver Stiffness Measurement.
- Published in:
- Digestion, 2012, v. 85, n. 3, p. 219, doi. 10.1159/000335430
- By:
- Publication type:
- Article
Hepatitis B Virus Serology to Predict Antiviral Response in Chronic Hepatitis B.
- Published in:
- Digestion, 2011, v. 84, p. 29, doi. 10.1159/000334076
- By:
- Publication type:
- Article
Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity.
- Published in:
- PLoS ONE, 2024, v. 19, n. 8, p. 1, doi. 10.1371/journal.pone.0307712
- By:
- Publication type:
- Article
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 965, doi. 10.3390/curroncol28010095
- By:
- Publication type:
- Article
Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma.
- Published in:
- Yonsei Medical Journal, 2015, v. 56, n. 5, p. 1296, doi. 10.3349/ymj.2015.56.5.1296
- By:
- Publication type:
- Article
Acute Variceal Hemorrhage in Patients with Liver Cirrhosis: Weekend versus Weekday Admissions.
- Published in:
- Yonsei Medical Journal, 2012, v. 53, n. 2, p. 318, doi. 10.3349/ymj.2012.53.2.318
- By:
- Publication type:
- Article
Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection.
- Published in:
- Oncology, 2011, v. 81, p. 41, doi. 10.1159/000333258
- By:
- Publication type:
- Article
Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 576, doi. 10.1002/cpdd.1045
- By:
- Publication type:
- Article
The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta‐analyses of randomized controlled trials.
- Published in:
- Obesity Reviews, 2022, v. 23, n. 9, p. 1, doi. 10.1111/obr.13464
- By:
- Publication type:
- Article
Statin use is associated with better post‐operative prognosis among patients with hepatitis B virus‐related hepatocellular carcinoma.
- Published in:
- European Journal of Clinical Investigation, 2023, v. 53, n. 4, p. 1, doi. 10.1111/eci.13936
- By:
- Publication type:
- Article
Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2021, v. 12, n. 5, p. 1168, doi. 10.1002/jcsm.12754
- By:
- Publication type:
- Article
Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 4, p. 289, doi. 10.1111/jvh.13656
- By:
- Publication type:
- Article
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 11, p. 1570, doi. 10.1111/jvh.13601
- By:
- Publication type:
- Article
No influence of hepatic steatosis on the 3‐year outcomes of patients with quiescent chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 11, p. 1545, doi. 10.1111/jvh.13594
- By:
- Publication type:
- Article
Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 10, p. 1362, doi. 10.1111/jvh.13560
- By:
- Publication type:
- Article
External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 6, p. 951, doi. 10.1111/jvh.13506
- By:
- Publication type:
- Article
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 1, p. 95, doi. 10.1111/jvh.13411
- By:
- Publication type:
- Article
A multi‐centre study of trends in hepatitis B virus‐related hepatocellular carcinoma risk over time during long‐term entecavir therapy.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 12, p. 1352, doi. 10.1111/jvh.13384
- By:
- Publication type:
- Article
Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 9, p. 932, doi. 10.1111/jvh.13313
- By:
- Publication type:
- Article
An observational study on long‐term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 316, doi. 10.1111/jvh.13222
- By:
- Publication type:
- Article
The risk of hepatocellular carcinoma among chronic hepatitis B virus‐infected patients outside current treatment criteria.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 12, p. 1465, doi. 10.1111/jvh.13185
- By:
- Publication type:
- Article
Editorial: High qHBsAg—is it a good or bad signal?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 9, p. 920, doi. 10.1111/apt.17699
- By:
- Publication type:
- Article
Meta‐analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 6, p. 600, doi. 10.1111/apt.17371
- By:
- Publication type:
- Article
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 1, p. 196, doi. 10.1111/apt.15741
- By:
- Publication type:
- Article